Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ophth. Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ophth. Other
    Eye Floaters, Flashes of Light Linked to Retinal Tear, Detachment - (DGNews)
    Acute-onset floaters and flashes: is this patient at risk for retinal detachment? - (JAMA)
    Proton Beam Radiation Therapy for Uveal Melanoma Yields Good Results at a Dose of 56 Gy: Presented at ASTRO - (DGDispatch)
    Intravitreal Triamcinolone Effective for Diabetic Macular Oedema - (DGNews)
    Topical Cyclosporine More Effective Than Artificial Tears for Treating Dry Eye: Presented at AAO-PAAO - (DGDispatch)

    News archive

     Recent webcasts/CME - Ophth. Other
    Treatment of Dry Eye
    Managing Age-Related Macular Degeneration - An Update

    Webcasts/CME archive

     Recent cases - Ophth. Other
      Frontal Skull Craniotomy Combined With Moderate-Dose Radiotherapy Effectively Ameliorate A Rare Case Of Non-Secretory, Multiple Myeloma With Orbital Involvement
      A Spontaneous Suprachoroidal Haemorrhage: A Case Report
      Long-Term Remission of Myopic Choroidal Neovascular Membrane After Treatment with Ranibizumab: A Case Report
      Ocular Disorders as the Prevailing Manifestations of Antiphospholipid Syndrome: A Case Series
      Primary Central Nervous System Lymphoma Presenting as Bilateral Uveitis in an Immunocompetent HCV+ Patient: A Case Report

      Cases archive
        




      my personal edition > ophth. other > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Moxifloxacin Concentrations Higher Than Gatifloxacin in Eye Surgery: Presented at ARVO

      By Michael Casasnovas

      FT. LAUDERDALE, F.L. -- May 4, 2006 -- Higher antimicrobial activity and concentration of moxifloxacin (Vigamox) when compared to gatifloxacin (Zymar) may help prevent common ocular pathogens associated with endophthalmitis and keratitis, according to research presented here at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting.

      "Following single topical administration, moxifloxacin intracorneal levels exceeded the minimum inhibitory concentration for the majority of pathogens causing bacterial keratitis and endophthalmitis," said Ed Holland, MD, director of cornea and external diseases, Cincinnati Eye Institute, Cincinnati, Ohio.

      Immediate antibiotic treatment is a key in preventing corneal scarring and potential visual acuity loss or blindness, Dr. Holland said. Fifty patients in need of penetrating keratoplasty were enlisted in this study at 6 centers across the United States. They were divided evenly into 2 groups to receive either moxifloxacin or gatifloxacin on the day of the surgery. These 2 groups were divided into 4 different times (15 minutes, 30 minutes, 1 hour, or 2 hours) for sample collection.

      Researchers used tuberculin syringes to transfer approximately 0.15 mL of aqueous humor, withdrawn from the anterior chamber, into a 1.5 mL conical polypropylene tube. They extracted a corneal button and stored it in a polypropylene cryogenic [storage] tube. Until researchers were prepared for analysis, the samples were frozen at -20°C for storage.

      Researchers analyzed the amount of moxifloxacin and gatifloxacin in the corneal tissue and the aqueous humor determining their ocular penetration.

      "Over the 2-hour collection period, mean stromal levels of moxifloxacin were at least 2-fold higher than those of gatifloxacin. Similarly, the mean levels of moxifloxacin in the corneal epithelium, endothelium, and aqueous humor were markedly higher at each time point than those of gatifloxacin," said Dr. Holland in the poster presentation on May 3rd.

      The results were significant (P <.05) for the area under the concentration-time curve, where it was observed that moxifloxacin levels were 2.3 to 4 times greater than that of gatifloxacin at all 4 collection times.

      When compared with the predicted corneal wound healing, researchers noted a quicker response to those on moxifloxacin at days 1, 3, and 7.


      [Presentation title: Human Cornea and Aqueous Humor Concentrations of Moxifloxacin and Gatifloxacin Following Topical Dosing With Vigamox Solution or Zymar. Abstract 3577]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send